X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Why won’t the insurance industry tell the truth about medicine costs?

By Robert Zirkelbach  |    May 10, 2017
Discussions about the cost of medicines are important. We recognize that many patients are struggling to access the medicines they need, and we want to work with policymakers and other health care...   Read More

4 Things to know about the QuintilesIMS Medicines Use and Spending in the U.S. report

By Holly Campbell  |    May 4, 2017
We have seen a deluge of data recently from government actuaries and pharmacy benefit managers showing a dramatic slowdown in medicine spending growth. And the QuintilesIMS Medicines Use and...   Read More

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

By Robert Zirkelbach  |    September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9...   Read More

What you need to know about the federal government’s health spending projections

By Holly Campbell  |    July 14, 2016
New National Health Expenditure (NHE) projections released today by the Centers for Medicare & Medicaid Services reaffirm how our nation’s competitive marketplace for medicines controls costs...   Read More

New report: Eliminating hepatitis C today could reduce future U.S. health care spending by $115 billion over the next decade

By Holly Campbell  |    September 24, 2015
Costs and Consequences is a blog series examining the health care burden of not treating diseases. Too often, the rhetoric focuses solely on the cost of medicines and disregards the adverse...   Read More

Yet Another Misleading Report on Medicine Prices

By Robert Zirkelbach  |    May 13, 2015
Today Express Scripts released yet another misleading report to promote a false narrative about medicine spending in the United States.  For more than 50 years, spending on medicines has...   Read More

What You Need to Know about the New Kaiser Poll

By Robert Zirkelbach  |    April 22, 2015
Spending on retail prescription medicines has consistently accounted for just 10 percent of health care spending, even though biopharmaceutical companies have brought more than 500 medicines to...   Read More

Medicare Monday: Gaining Part D Coverage Reduces Hospitalizations and Overall Spending in Medicare

By Allyson Funk  |    March 30, 2015
As you learned in last week’s video, Medicare Part D helps seniors adhere to their medicines by providing access to prescription drug coverage. This helps beneficiaries live healthier lives by...   Read More

The Five Essential Truths about Prescription Drug Spending

By Robert Zirkelbach  |    March 10, 2015
This blog post has been updated. Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail...   Read More

New Report: Forecasts for Specialty Medicines Have Been Overstated

By Jennifer Bryant  |    February 9, 2015
According to a new report from actuaries Gabriela Dieguez, Bruce Pyenson and Jennifer Carioto, at Milliman, major pharmacy benefits managers (PBMs) often overestimate future spending on specialty...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates